Hormonal Contraceptive Market Revenue Drivers Growth Opportunities Supply Chain Analysis and Forecast Research Report Till 2025
“Global Hormonal Contraceptive Market is expected to reach USD 26.2 billion by 2025 with CAGR of 4.0% over the future period as the scope and its applications are rising enormously across the globe.”
The global Hormonal Contraceptive Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: Global Hormonal Contraceptive Market is expected to reach USD 26.2 billion by 2025. The hormonal contraceptive is termed as a birth control method, which acts on an endocrine system. The method is mainly used to prevent ovulation using female hormones. Progesterone and/or estrogen, or combination of these hormones are the two main forms of hormonal contraception. These hormones may be implanted into body tissue, absorbed from a patch on the skin, may be taken orally, injected under the skin, or placed in the vagina. Key Players:
Allergan Bayer AG Merck & Co., Inc. Pfizer Afaxys, Inc. Teva Pharmaceutical Industries Ltd Agile Therapeutics Apothecus Pharmaceutical Corp.